NASDAQ: ALMR
Alamar Biosciences Inc Earnings Dates, Reports, Calls

Alamar Biosciences earnings were -$29.8M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest ALMR earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ALMR reported annual earnings of -$29.8M, with -35.6% growth.

ALMR earnings history

Current Revenue
$74.2M
Current Earnings
-$29.8M
Current Profit Margin
-40.2%

ALMR Return on Equity

Insufficient data to display

ALMR Return on Assets

Current Company
-20.6%
Current Industry
5.4%

Be the first to know when ALMR announces earnings.

ALMR Return on Capital Employed

Current Company
-24.73%
Current Industry
9.4%

ALMR vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AIDX-$3.50M-$3.74MN/A-$0.76
AIMD-$9.28M-$14.77MN/A-$3.46
ALMR-$22.96M-$29.82MN/A-$2.58
ALGN$862.47M$410.35M-24.15%$5.66
ADGM-$21.21M-$25.08MN/A-$1.51

Alamar Biosciences Earnings Reports & History FAQ

What were Alamar Biosciences's earnings last quarter?

Alamar Biosciences (NASDAQ: ALMR) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total ALMR earnings for the quarter were N/A. In the same quarter last year, Alamar Biosciences's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Alamar Biosciences stock.

Is Alamar Biosciences profitable or losing money?

As of the last Alamar Biosciences earnings report, Alamar Biosciences is currently losing money. Alamar Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$29.82 million, a 35.55% decrease year over year.

What was ALMR's earnings growth in the past year?

As of Alamar Biosciences's earnings date in Q2 2026, Alamar Biosciences's earnings has grown year over year. ALMR earnings in the past year totalled -$29.82 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.